Filing Details
- Accession Number:
- 0000899243-18-012352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-10 16:44:46
- Reporting Period:
- 2018-05-09
- Accepted Time:
- 2018-05-10 16:44:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614936 | Roger Pomerantz | C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-09 | 233 | $9.00 | 324,304 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2018.
Billionaire Hedge Funds
